Markers of increased cardiovascular risk: Are we measuring the most appropriate parameters?

被引:19
|
作者
Hawkins, MA [1 ]
机构
[1] Albert Einstein Coll Med, Dept Med, Div Endocrinol, Ctr Diabet Res & Training, Bronx, NY 10461 USA
来源
OBESITY RESEARCH | 2004年 / 12卷
关键词
cardiovascular disease risk; high-density lipoprotein/total cholesterol ratio; small dense low-density lipoproteins; C-reactive protein; postprandial glucose levels;
D O I
10.1038/oby.2004.275
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The vital task of evaluating cardiovascular disease risk in individual patients is challenging in light of the ever-growing list of risk factors. Some of the traditional measures of cardiovascular risk, such as blood lipid levels, have been further refined to provide better risk assessments. Certain specific parameters, such as lipoprotein buoyancy, seem to be better predictors of cardiovascular disease than total lipoprotein levels. Furthermore, as the contribution of systemic inflammation to the pathogenesis of atherosclerosis is increasingly. recognized, several inflammatory markers have become associated with disease risk. Consequently, many studies have attempted to determine the individual merits of these factors in predicting cardiovascular risk.
引用
收藏
页码:107S / 114S
页数:8
相关论文
共 50 条
  • [21] Most siblings "are not at increased risk"
    不详
    EUROPEAN JOURNAL OF CANCER, 2001, 37 (17) : 2138 - 2138
  • [22] Groundwater pollution:: Are we monitoring appropriate parameters?
    Tredoux, G
    Cavé, L
    Engelbrecht, P
    WATER SA, 2004, 30 (05) : 662 - 667
  • [23] Do we have markers to define the cardiovascular risk in rheumatoid arthritis patients?
    Atzeni, F.
    Sarzi-Puttini, P.
    REUMATISMO, 2009, 61 (01) : 1 - 3
  • [24] THE IMPACT OF OBESITY TO ANTIOXIDANT DEFENSE PARAMETERS IN ADOLESCENTS WITH INCREASED CARDIOVASCULAR RISK
    Colak, Emina
    Pap, Dragana
    Nikolic, Ljubinka
    Vickovic, Sanja
    JOURNAL OF MEDICAL BIOCHEMISTRY, 2020, 39 (03) : 346 - 354
  • [25] Growth hormone deficiency and cardiovascular risk: do we need additional markers?
    M. Gola
    A. Giustina
    Endocrine, 2012, 42 : 240 - 242
  • [26] Growth hormone deficiency and cardiovascular risk: do we need additional markers?
    Gola, M.
    Giustina, A.
    ENDOCRINE, 2012, 42 (02) : 240 - 242
  • [27] Obesity adolescents: novel targets for increased cardiovascular risk and antioxidant parameters
    Pap, D.
    Jurisic, V.
    CLINICA CHIMICA ACTA, 2022, 530 : S208 - S208
  • [28] Increased cardiovascular risk markers in obesity are associated with body adiposity:: Role of leptin
    Gomez-Ambrosi, Javier
    Salvador, Javier
    Silva, Camilo
    Pastor, Carlos
    Rotellar, Fernando
    Gil, Maria J.
    Cienfuegos, Javier A.
    Fruhbeck, Gema
    THROMBOSIS AND HAEMOSTASIS, 2006, 95 (06) : 991 - 996
  • [29] Cardiovascular risk markers are increased in HIV-infected children with lipodystrophy syndrome
    Guzman-Fulgencio, Maria
    Micheloud, Dariela
    Lorente, Raquel
    Maria Bellon, Jose
    de Jose Gomez, Maria Isabel
    Dolores Gurbindo, Maria
    Antonio Leon, Juan
    Angeles Munoz-Fernandez, Maria
    Resino, Salvador
    JOURNAL OF INFECTION, 2011, 62 (03) : 240 - 243
  • [30] Increased diabetes and cardiovascular disease risk markers in first episode psychosis subjects
    Graham, K
    Cho, H
    Brownley, K
    SCHIZOPHRENIA RESEARCH, 2006, 81 : 135 - 135